In addition to these, Wnt/CTNNB1 mutation is a characteristic of immune rejection (cold tumor) and maybe a biomarker for predicting drug resistance of immunosuppressants at immune checkpoints in HCC (Pinyol et al., 2019). The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.